ResMed Inc. vs SP Funds S&P 500 Sharia Industry Exclusions ETF — how do they compare? ResMed Inc. trades at $220 (market cap $32.61B), while SP Funds S&P 500 Sharia Industry Exclusions ETF trades at $59.26. The key difference: ResMed Inc. pays a 1.17% dividend while SP Funds S&P 500 Sharia Industry Exclusions ETF pays none, and SP Funds S&P 500 Sharia Industry Exclusions ETF is trading nearer its 52-week high, ResMed Inc. nearer its low. Which is the better fit depends on your goals.
| RMD | SPUS | |
|---|---|---|
Market Cap | $32.61B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $293.73 | $59.51 |
52-Week Low | $182.82 | $46.28 |
Enterprise Value | $31.97B | — |
Dividend Yield | 1.17% | — |
Trailing returns across standard periods
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →SPUS tracks a market-cap weighted index of S&P 500 stocks that adhere to Sharia law. It screens out companies involved in non-compliant business activities such as alcohol, tobacco, gambling, and conventional finance, as well as excluding sectors like Aerospace & Defense, and Data Processing. By focusing on low-leverage stocks, SPUS provides investors with a value-conscious, ethically-aligned exposure to a diversified portfolio of large-cap U.S. equities.
Read more on SPUS →